BMS-F
# BMS-F

BMS-F is a chemical from the aminoalkylindole family invented by Bristol-Myers Squibb around 1999, that acts as a potent and selective agonist for the cannabinoid receptor $CB_2,$ with a $K_i$ of 8 nM at $CB_2$ and 500x selectivity over the related $CB_1$ receptor. It has antiinflammatory effects and inhibits release of TNF-α.

